Man with back pain Despite the increased spending on MSK therapies between 2010 and 2019, many MSK treatments simply aren’t providing a long-term solution, instead relying on “quick fix” injections or costly surgeries. (Photo: Shutterstock)

A new report finds that treatment of musculoskeletal (MSK) issues has doubled in recent years—with no improvement in patient outcomes.

The “State of MSK Report, 2021” was released by Hinge Health, a digital health company that specializes in MSK treatment. The report noted that MSK issues are a top health care cost for many employers, and that the new trend toward remote work may result in an increase in claims in this area, since many home workspaces are not set up to be ergonomically sound.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.